These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10599863)

  • 21. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.
    Tsukada H; Nishiyama S; Fukumoto D; Sato K; Kakiuchi T; Domino EF
    Neuropsychopharmacology; 2005 Oct; 30(10):1861-9. PubMed ID: 15841110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.
    Parsons CG; Danysz W; Quack G
    Neuropharmacology; 1999 Jun; 38(6):735-67. PubMed ID: 10465680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of glutamate and MK-801 on the metabolism of dopamine in the striatum of normal and parkinsonian rats.
    Duan CL; Sun XH; Ji M; Yang H
    Sheng Li Xue Bao; 2005 Feb; 57(1):71-6. PubMed ID: 15719139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study.
    Hagino Y; Moroji T
    Brain Res; 1994 Apr; 644(1):40-6. PubMed ID: 8032948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN; Ansseau M; Lemaire M; Abraini JH
    Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease.
    Tronci E; Fidalgo C; Zianni E; Collu M; Stancampiano R; Morelli M; Gardoni F; Carta M
    Neuroscience; 2014 Apr; 265():245-52. PubMed ID: 24486947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine.
    Meisner F; Scheller C; Kneitz S; Sopper S; Neuen-Jacob E; Riederer P; ter Meulen V; Koutsilieri E;
    Neuropsychopharmacology; 2008 Aug; 33(9):2228-36. PubMed ID: 17971830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge.
    Birgner C; Kindlundh-Högberg AM; Nyberg F; Bergström L
    Neurosci Lett; 2007 Jan; 412(2):168-72. PubMed ID: 17123707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755.
    Waters N; Lundgren C; Hansson LO; Carlsson ML
    J Neural Transm (Vienna); 1996; 103(1-2):117-29. PubMed ID: 9026366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic hypercortisolemia inhibits dopamine synthesis and turnover in the nucleus accumbens: an in vivo microdialysis study.
    Pacak K; Tjurmina O; Palkovits M; Goldstein DS; Koch CA; Hoff T; Chrousos GP
    Neuroendocrinology; 2002 Sep; 76(3):148-57. PubMed ID: 12218347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.
    Jentsch JD; Dazzi L; Chhatwal JP; Verrico CD; Roth RH
    Neurosci Lett; 1998 Dec; 258(3):175-8. PubMed ID: 9885959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats.
    Kotermanski SE; Johnson JW; Thiels E
    Pharmacol Biochem Behav; 2013 Aug; 109():67-76. PubMed ID: 23665480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress-induced activation of prefrontal cortex dopamine turnover: blockade by lesions of the amygdala.
    Davis M; Hitchcock JM; Bowers MB; Berridge CW; Melia KR; Roth RH
    Brain Res; 1994 Nov; 664(1-2):207-10. PubMed ID: 7895029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man.
    Kornhuber J; Quack G
    Neurosci Lett; 1995 Aug; 195(2):137-9. PubMed ID: 7478269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of FG 7142-induced increased dopamine utilization by the glycine/NMDA receptor antagonist (+)-HA 966.
    Horger BA; Elsworth JD; Roth RH
    J Neurochem; 1996 May; 66(5):1959-62. PubMed ID: 8780023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.
    Verma A; Moghaddam B
    J Neurosci; 1996 Jan; 16(1):373-9. PubMed ID: 8613804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential stimulation of extracellular release of dopamine in rat frontal cortex to striatum following competitive inhibition of the N-methyl-D-aspartate receptor.
    Nishijima K; Kashiwa A; Nishikawa T
    J Neurochem; 1994 Jul; 63(1):375-8. PubMed ID: 8207441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine.
    Radu D; Brodin E; Weber G; Lindefors N
    Brain Res; 2001 Jul; 908(2):197-203. PubMed ID: 11454330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex.
    Yoshitake T; Yoshitake S; Kehr J
    Br J Pharmacol; 2010 Feb; 159(3):659-68. PubMed ID: 20105177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.